Artificial intelligence (AI) is rapidly becoming an important tool across pharmaceutical and biopharmaceutical research. Applications ranging from drug discovery and biologics development to formulation screening and quality assessment increasingly rely on machine learning to identify patterns, accelerate decision-making, and improve development efficiency.
Despite advances in algorithms and computing power, many organizations face a common challenge: obtaining experimental data that is suitable for AI applications. Machine learning (ML) models can only perform as well as the data used to train them. As a result, the quality, quantity, and consistency of analytical data are becoming critical considerations for laboratories seeking to implement AI-driven workflows.
For lab managers, this raises an important question: What makes analytical data “AI-ready,” and how can laboratories generate it efficiently?
The data challenge behind AI
The pharmaceutical industry generates enormous amounts of analytical data. However, not all data are equally useful for machine learning.
Many traditional analytical methods were developed to answer highly specific questions, often producing a small number of results per sample. While these techniques remain valuable and often indispensable, they may not always provide the multidimensional datasets needed to support modern data analytics and ML approaches.
AI models generally benefit from datasets that are:
- High in quality and reproducibility
- Generated in sufficient volume
- Rich in molecular or chemical information
- Consistent across time and operators
- Compatible with data management and analytics platforms
Generating such datasets can become a bottleneck in research programs that seek to apply ML to complex biological or chemical systems.
As organizations invest in AI, attention is increasingly shifting away from algorithms alone and toward the analytical technologies that generate the underlying data.
What makes spectroscopy different?
Spectroscopy offers a unique advantage because it captures comprehensive molecular information in a single measurement.
Unlike assays that may provide a limited number of outputs, spectroscopic techniques often generate molecular fingerprints containing hundreds or thousands of variables. These fingerprints reflect the chemical composition and molecular characteristics of a sample, creating multidimensional datasets that are well suited for chemometrics and ML.
Rather than focusing on a single analyte or attribute, spectroscopic measurements frequently provide a holistic view of a sample. This broader perspective can help reveal subtle differences between formulations, biological products, or experimental conditions that may otherwise be difficult to detect.
For ML applications, these rich datasets can improve opportunities to identify relationships, classify samples, detect anomalies, and develop predictive models.
Fluorescence fingerprinting for product characterization
Among the spectroscopy techniques attracting increased interest is fluorescence molecular fingerprinting.
Advanced fluorescence methods can capture excitation-emission relationships across a broad range of wavelengths, generating detailed fingerprints that reflect the molecular composition of a sample. When combined with absorbance measurements, these techniques provide highly information-rich datasets without the need for extensive sample preparation or time-consuming separations.
Figure 1. A-TEEM spectroscopy enables chemical characterization and quantitative analysis of antibody-drug conjugates. The A-TEEM contour reveals a characteristic protein fluorescence signature derived from aromatic amino acids, centered at an excitation/emission wavelength pair of approximately 280/330 nm. In contrast, the payload exhibits a unique fluorescence fingerprint with two prominent excitation/emission maxima located at approximately 260/450 nm and 375/450 nm, respectively.
In pharmaceutical and biopharmaceutical research, fluorescence fingerprinting has potential applications in:
- Monoclonal antibody differentiation
- Cell culture media characterization
- Vaccine characterization
- Protein stability studies
- Viral vector analysis
- Antibody drug conjugate analysis
- Product comparability assessments
Because measurements can often be performed rapidly, fluorescence-based approaches can enable laboratories to generate larger datasets than may be practical with more labor-intensive workflows. This increased throughput can be particularly valuable when building ML models that benefit from greater data diversity and sample coverage.
Raman spectroscopy and high-throughput screening
Raman spectroscopy offers a complementary source of molecular information by probing molecular vibrations and chemical structure.
In recent years, advances in automation have made Raman analysis increasingly compatible with high-throughput screening workflows. Rather than evaluating samples individually through traditional microscope-based approaches, modern automated platforms can rapidly analyze large numbers of samples while maintaining high spectral quality.
Figure 2. Raman spectroscopy enables chemical identification and quantitative analysis of formulation components. The reference spectra of the active pharmaceutical ingredient (API) and excipients were compared with the spectrum of a representative formulation containing 10% API and 90% excipients. The results demonstrate the capability of Raman spectroscopy to distinguish API-specific spectral features and support formulation screening and quantitative compositional analysis.
For pharmaceutical laboratories, this capability opens new opportunities in areas such as:
- Formulation screening
- Drug candidate evaluation
- Reaction screening
- Material characterization
- Quality assessment studies
The combination of Raman spectroscopy and laboratory automation can significantly expand the volume of molecular data generated during development programs. As dataset size increases, researchers gain greater opportunities to train ML models capable of identifying trends, predicting outcomes, or prioritizing promising candidates for further investigation.
Lab Quality Management Certificate
The Lab Quality Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
Evaluating analytical technologies for AI applications
As interest in AI continues to grow, lab managers may benefit from evaluating analytical technologies through a different lens than traditional performance metrics alone.
In addition to sensitivity, accuracy, and precision, several questions may become increasingly important:
1. How information-rich is each measurement?
Techniques that generate multidimensional datasets may provide greater value for ML applications than methods producing only a few measured parameters.
2. Can the platform generate data at scale?
Large, diverse datasets are often important for developing robust predictive models. Throughput and ease of use can therefore become critical considerations.
3. Is the data reproducible?
ML algorithms are highly sensitive to data quality. Consistent measurements across instruments, operators, and time are essential.
4. Can the system integrate with data infrastructure?
Data management, storage, and accessibility are increasingly important. Analytical platforms that facilitate integration with laboratory information systems and analytics environments may help accelerate AI initiatives.
5. Does the technique support automation?
Interested in lab leadership?
Register for a FREE Lab Manager account to subscribe to our Lab Leadership Digest Newsletter.
Automated workflows can improve consistency, increase throughput, and support the generation of larger datasets while reducing manual effort.
By considering these factors, laboratories can better assess whether an analytical technology is positioned to support future AI-driven research strategies.
Looking ahead
The pharmaceutical and biopharmaceutical industries continue to invest heavily in artificial intelligence, yet success ultimately depends on the availability of meaningful experimental data.
Data-rich spectroscopy techniques such as fluorescence fingerprinting and Raman spectroscopy offer a promising route toward generating the large, multidimensional datasets required for machine learning. By capturing comprehensive molecular information quickly and reproducibly, these approaches can help laboratories strengthen product characterization, improve screening workflows, and support the development of more powerful predictive models.
As AI becomes increasingly integrated into pharmaceutical research and development, the laboratories most likely to succeed may be those that view data generation as a strategic capability rather than simply a routine analytical task. The future of AI in pharma will depend not only on better algorithms, but also on better molecular data.
Leave a Reply